One thing which has caused a lot of problems with mRNA tech, and indeed all genetic tech, is that tolerably often it looks great at first, but the longer term effects are brutal. The companies now have these products in development, and they want to market them before they finish the long term trials, and the regulators cannot really ask for long term safety data, not after telling everyone that it's not needed for another product of the same sort.
![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png)
branchandroot
Re: Are we seeing a doubling down?
Date: 2022-12-13 09:02 pm (UTC)